Skip to main content

Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
1.95
+0.03 (1.56%)
At close: Dec 29, 2023, 4:00 PM
1.92
-0.03 (-1.54%)
After-hours: Dec 29, 2023, 6:55 PM EST

Agile Therapeutics Revenue

Agile Therapeutics had revenue of $19.97M in the twelve months ending September 30, 2023, with 137.70% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $6.66M with 121.92% year-over-year growth. In the year 2022, Agile Therapeutics had annual revenue of $10.88M with 165.40% growth.

Revenue (ttm)
$19.97M
Revenue Growth
+137.70%
P/S Ratio
0.25
Revenue / Employee
$907,909
Employees
22
Market Cap
4.90M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202210.88M6.78M
165.40%
Dec 31, 20214.10M3.35M
447.53%
Dec 31, 2020749.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AGRX News

More News